People find a vein clinic for two different reasons. Some have aching, heavy or swollen legs and want relief. Others simply do not like how spider veins or bulging veins look. Many have both concerns, and nearly all of them want to know whether insurance will pay.
That mix of medical and cosmetic care is what makes vein marketing tricky. The words a clinic uses about symptoms, appearance, coverage and results all carry rules. This guide covers how to describe treatment accurately, the Medicare line between cosmetic and medically necessary services, free screening offers, device wording, result claims and patient photos, and ad targeting. It does not cover which treatment suits which patient, which is a clinical decision. For leg fat disorders treated alongside vein disease, see our guide to lipedema treatment marketing.
This is general information, not legal or medical advice. Sources cited were checked on October 29, 2026: the NHLBI Varicose Veins pages (National Institutes of Health, last updated September 26, 2023), the MedlinePlus Varicose Veins page (National Library of Medicine, last updated June 27, 2025), 42 U.S.C. 1395y (Medicare exclusions, including services that are not reasonable and necessary and cosmetic surgery), 42 CFR 411.15(h), 42 U.S.C. 1320a-7a, the HHS OIG Policy Statement Regarding Gifts of Nominal Value (December 7, 2016), 21 CFR 807.97, the FTC Health Products Compliance Guidance, 16 CFR 255.2 and Part 465, 45 CFR 164.508 and Meta’s Health and Wellness ad policy. Medicare contractors and private plans set their own detailed coverage criteria, and state medical boards regulate physician advertising. Have a health care attorney review your marketing.
Describe treatment the way NHLBI does
The National Heart, Lung, and Blood Institute (NHLBI) describes the symptoms of varicose veins as including pain, heaviness and swelling in the legs, and notes that symptoms may get worse with long periods of sitting or standing. It says the goal of treatment is to relieve symptoms, keep varicose veins from worsening, improve appearance and prevent serious complications such as ulcers and bleeding.
NHLBI describes the main procedures in plain terms: endovenous ablation, which uses laser or radiofrequency energy to close a vein, usually in a doctor’s office with ultrasound guidance; sclerotherapy, which injects liquid or foam chemicals to seal a vein, with liquid more often used for spider veins; and surgery for larger, deeper veins. It notes that most procedures are minimally invasive and do not require a long recovery, and it also lists side effects: bruising, pain and skin color changes are common after ablation, and foam sclerotherapy can rarely cause venous thromboembolism, nerve damage, a serious allergic reaction or stroke.
Two NHLBI points matter most for marketing. First, it says new varicose veins may form even after treatment, and that some people need treatment more than once. Second, it presents procedures alongside compression and lifestyle measures, depending on how serious the symptoms are. A page that says gone for good, permanent results or no downtime for everyone says more than the federal description supports.
- Avoid permanent, gone forever and guaranteed. NHLBI says new veins may form and repeat treatment may be needed.
- Avoid pain-free and no risk. Describe what patients usually feel and the risks your providers explain at consultation.
- Describe each procedure, where it is done, how long it takes and what follow-up involves, in the same plain terms.
Cosmetic or medically necessary: be careful with coverage claims
Medicare does not pay for everything a vein clinic does. Under 42 U.S.C. 1395y(a)(1)(A), Medicare does not pay for items and services that are not reasonable and necessary for the diagnosis or treatment of illness or injury. Section 1395y(a)(10) and 42 CFR 411.15(h) separately exclude cosmetic surgery and related services, except as required for the prompt repair of accidental injury or to improve the functioning of a malformed body member. Medicare contractors and private plans can also set more detailed coverage criteria.
For marketing, that means three things:
- Do not say insurance covers vein treatment. Say that some treatment may be covered when it is medically necessary, that coverage depends on the plan and documentation, and that your team will check.
- Keep cosmetic services clearly labeled. Medicare excludes cosmetic surgery, so treatment for appearance alone is generally not covered for Medicare patients, and private plans vary. Say so plainly, with price scope if you publish prices.
- Do not blur the two. Ads that invite people with cosmetic concerns to come in for an insurance-covered evaluation can mislead patients and invite scrutiny of the services you bill.
Free vein screenings
Free screening events are common in vein marketing. If any attendees have Medicare or Medicaid, remember 42 U.S.C. 1320a-7a(a)(5), which penalizes offering remuneration to beneficiaries that is likely to influence their choice of provider, and defines remuneration to include items and services given free or for less than fair market value. HHS OIG’s 2016 policy statement interprets nominal value as no more than 15 dollars per item or 75 dollars in the aggregate per patient per year. A free screening that leads straight into billable procedures for Medicare patients deserves review by counsel before you advertise it.
Devices: cleared is not approved
Some devices used in vein care reach the market through FDA’s 510(k) premarket notification process; check the clearance for each device you use. 21 CFR 807.97 says a substantial equivalence determination does not in any way denote official approval of the device, and that any representation creating an impression of official approval because of complying with the premarket notification rules is misleading and constitutes misbranding. Say FDA cleared, not FDA approved, for a 510(k) device, and only for the specific device you use. Our guide to hair restoration clinic marketing explains the same rule with another device category.
Result claims, photos and reviews
The FTC Health Products Compliance Guidance says claims about the health benefits of health-related products and services require competent and reliable scientific evidence, and that advertisers are responsible for implied claims as well as express ones. Under the Endorsement Guides, 16 CFR 255.2(b), an ad that shows one patient’s result on a key point is likely to be read as typical, so without substantiation it should clearly disclose the generally expected results.
Leg photos your clinic took are protected health information. Under 45 CFR 164.508, using them for marketing generally requires the patient’s written authorization meeting that section’s requirements. Many clinics avoid before and after images entirely and show the treatment room, the team and the steps of a visit instead. Our guide to patient testimonials and before-and-after photos covers both rules.
16 CFR Part 465 prohibits fake reviews, and section 465.4 prohibits incentives conditioned on reviews expressing a particular sentiment. Ask every patient for honest feedback, and keep replies general; see our guide to replying to patient reviews.
Arterial disease is a different service with different rules. If your practice also treats peripheral artery disease in an office-based lab, see our office-based lab marketing guide.
Ads and targeting
Meta’s Health and Wellness ad policy says ads promoting cosmetic procedures must be targeted to people at least 18 years old, and that ads must not contain statements that attack a person’s appearance or specific body parts. Ads built around embarrassment about legs run into that rule. Ads that describe symptoms in neutral terms and invite people to a consultation fit it better.
On Google, search ads for vein care work best when each ad group matches one service and its landing page: symptom evaluation, varicose vein treatment, spider vein treatment. Keep cosmetic and medical pages separate so the claims on each stay accurate. Our Google Ads for practices page explains how we structure campaigns around health policies, and our guide to healthcare ad policy basics covers the main platforms.
What tends to work, inside the rules
- Separate symptom and cosmetic pages. One page for leg symptoms and evaluation, one for spider vein treatment for appearance, each honest about coverage.
- A clear first visit page. What the consultation covers, whether an ultrasound may be done, and how the team checks insurance.
- Procedure pages in NHLBI’s terms. What each procedure is, where it is done, common side effects, follow-up and that new veins can form.
- Referral relationships. Primary care, podiatry and wound care clinicians see patients with leg symptoms. Share what you do and how to refer, with nothing of value tied to referrals; our guide to patient and physician referrals explains why.
- Fast answers. Staff or an AI front desk can answer general questions about visits and coverage checks and pass clinical questions to the team.
Can a vein clinic say results are permanent?
Avoid it. NHLBI says new varicose veins may form even after treatment and that some people need treatment more than once. Describe what each procedure does instead.
Can we say insurance covers vein treatment?
Not as a blanket claim. Medicare excludes services that are not reasonable and necessary and excludes cosmetic surgery under 42 U.S.C. 1395y and 42 CFR 411.15(h). Say some treatment may be covered when medically necessary and that your team will check the patient’s plan.
Can we offer free vein screenings?
Be careful with Medicare and Medicaid patients. 42 U.S.C. 1320a-7a(a)(5) penalizes remuneration likely to influence a beneficiary’s choice of provider, including free services. Have counsel review the offer before you advertise it.
Can we say our ablation device is FDA approved?
Not if it was cleared through a 510(k). 21 CFR 807.97 says clearance does not denote official approval and implying approval is misbranding. Say FDA cleared, for the specific device.
Can we post before and after photos of legs?
Only with written authorization under 45 CFR 164.508, and under 16 CFR 255.2(b) a result shown in an ad is likely to be read as typical, so disclose generally expected results unless you can substantiate it.
Sources
- NHLBI (NIH): Varicose Veins (last updated September 26, 2023)
- MedlinePlus (National Library of Medicine): Varicose Veins (last updated June 27, 2025)
- 42 U.S.C. 1395y: Exclusions from coverage and Medicare as secondary payer (subsections a(1)(A) and a(10))
- 42 CFR 411.15: Particular services excluded from coverage (paragraph h, cosmetic surgery)
- 42 U.S.C. 1320a-7a: Civil monetary penalties (beneficiary inducement, subsection a(5))
- HHS OIG: Policy Statement Regarding Gifts of Nominal Value to Medicare and Medicaid Beneficiaries (December 7, 2016)
- 21 CFR 807.97: Misbranding by reference to premarket notification
- FTC: Health Products Compliance Guidance (December 2022)
- 16 CFR 255.2: Consumer endorsements
- 16 CFR Part 465: Use of consumer reviews and testimonials
- 45 CFR 164.508: Uses and disclosures for which an authorization is required
- Meta: Health and Wellness ad policy
More in Physician specialty marketing